Cintas vs Science Applications Intl
Add, change or remove companies; up to four.
The short version
- Cintas is the larger business, with $11.3B of revenue in fiscal 2026 against $7.3B for Science Applications Intl, about 1.6 times as much.
- Cintas grew revenue faster (8.9%, against −2.9%).
- Cintas kept more of each dollar of sales as operating profit (23.1% operating margin, against 7.2%).
- Cintas turned more of its sales into free cash flow (16.7% FCF margin, against 8.0%).
- Cintas earned a higher return on the capital invested in it (31.7%, against 12.8%).
- Investors pay more for each dollar of Cintas’s earnings: a P/E of 44.2x against 17.0x for Science Applications Intl.
| Latest fiscal year | CTAS · FY26 | SAIC · FY26 |
|---|---|---|
| Size | ||
| Market cap | $90.6B | $6.2B |
| Revenue | $11.3B | $7.3B |
| Free cash flow | $1.9B | $577M |
| Net income | $2.0B | $358M |
| Growth | ||
| Revenue growth | 8.9% | −2.9% |
| 5-year growth | 9.6% | 0.6% |
| Share count change | −1.0% | −7.9% |
| Profitability | ||
| Gross margin | 50.7% | 12.0% |
| Operating margin | 23.1% | 7.2% |
| Net margin | 17.8% | 4.9% |
| FCF margin | 16.7% | 8.0% |
| Return on capital | 31.7% | 12.8% |
| Return on equity | 40.7% | 23.3% |
| Balance sheet | ||
| Net debt | $1.1B | $2.3B |
| Net debt / EBITDA | 0.4x | 4.2x |
| Dividends and buybacks | $1.7B | $515M |
| Valuation & quality | ||
| P/E | 44.2x | 17.0x |
| Piotroski F-score | 8 | 7 |
Revenue
FY17
CTAS $5.3B
SAIC $4.4B
FY18
CTAS $6.5B
SAIC $4.5B
FY19
CTAS $6.9B
SAIC $4.7B
FY20
CTAS $7.1B
SAIC $6.4B
FY21
CTAS $7.1B
SAIC $7.1B
FY22
CTAS $7.9B
SAIC $7.4B
FY23
CTAS $8.8B
SAIC $7.7B
FY24
CTAS $9.6B
SAIC $7.4B
FY25
CTAS $10.3B
SAIC $7.5B
FY26
CTAS $11.3B
SAIC $7.3B
CTAS
SAIC
Operating margin
FY17
CTAS 14.5%
SAIC 5.9%
FY18
CTAS 14.7%
SAIC 5.8%
FY19
CTAS 16.5%
SAIC 4.7%
FY20
CTAS 16.4%
SAIC 5.8%
FY21
CTAS 19.5%
SAIC 5.5%
FY22
CTAS 20.2%
SAIC 6.3%
FY23
CTAS 20.5%
SAIC 6.5%
FY24
CTAS 21.6%
SAIC 10.0%
FY25
CTAS 22.8%
SAIC 7.5%
FY26
CTAS 23.1%
SAIC 7.2%
CTAS
SAIC
Free cash flow
FY17
CTAS $491M
SAIC $258M
FY18
CTAS $692M
SAIC $195M
FY19
CTAS $791M
SAIC $156M
FY20
CTAS $1.1B
SAIC $437M
FY21
CTAS $1.2B
SAIC $709M
FY22
CTAS $1.3B
SAIC $482M
FY23
CTAS $1.3B
SAIC $507M
FY24
CTAS $1.7B
SAIC $369M
FY25
CTAS $1.8B
SAIC $458M
FY26
CTAS $1.9B
SAIC $577M
CTAS
SAIC
Return on capital
FY17
CTAS 13.4%
SAIC 14.5%
FY18
CTAS 17.1%
SAIC 17.9%
FY19
CTAS 16.3%
SAIC 7.8%
FY20
CTAS 16.9%
SAIC 9.1%
FY21
CTAS 22.8%
SAIC 8.6%
FY22
CTAS 24.8%
SAIC 9.1%
FY23
CTAS 24.1%
SAIC 10.1%
FY24
CTAS 27.0%
SAIC 14.7%
FY25
CTAS 29.4%
SAIC 12.7%
FY26
CTAS 31.7%
SAIC 12.8%
CTAS
SAIC
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.